Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer

Author： Farrow D.C.  

Publisher： Springer Publishing Company

ISSN： 0957-5243

Source： Cancer Causes and Control, Vol.11, Iss.3, 2000-03, pp. : 231-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma

By                  

Oncology Letters, Vol. 6, Iss. 1, 2013-01 ,pp. : 13-18

Spandidos Publications

Access to resources Recommend Favorite

H2-antagonists in the treatment of colon and breast cancer

By Bolton E.   King J.   Morris D.L.  

Seminars in Cancer Biology, Vol. 10, Iss. 1, 2000-02 ,pp. : 3-10

Academic Press

Access to resources Recommend Favorite

Polymorphisms of mismatch repair gene hMLH1 and hMSH2 and risk of gastric cancer in a Chinese population

By              

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 591-598

Spandidos Publications

Access to resources Recommend Favorite

Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution

By                  

Molecular Medicine Reports, Vol. 5, Iss. 4, 2012-01 ,pp. : 1043-1048

Spandidos Publications

Access to resources Recommend Favorite

胃食管反流病与恶性肿瘤化疗关系的探讨Relation between Gastroesophageal Reflux Disease and Malignant Tumor Chemotherapy

By 刘汉山   朱海杭  

World Journal of Cancer Research, Vol. 4, Iss. 3, 2014-07 ,pp. : 33-39

汉斯出版社

Access to resources Recommend Favorite